Sarah Albertson, BS
Scientist I
Roy Amariglio, PhD, MBA
Principal, OrbiMed, Board Observer
Ruth Berry, PhD
Director, Analytical Development Strategy
Rebecca Brunette, PhD
Associate Director, Product Sciences and Characterization
Jane Buckner, MD
President, Benaroya Research Institute and Scientific Co-founder
Alaina Burgess, BS
Associate Scientist I
Heidi Chandler, BS
Senior Director, Program Management
Tiffany Chen, Ph.D.
VP, Discovery
Erez Chimovitz, MBA
Partner, OrbiMed, Chairman of the Board
Brian Christin, BS
Senior Director, CMC Strategy Lead
Adam Cotton, PhD, MBA
Associate, Novartis Venture Fund (NVF), Board Observer
Emilie Coueignoux, MBA
VP, Business Development
Tom Crevier, PhD
Senior Director, Automation, Informatics, and IT
Tristan de Jesús, PhD
Scientist I
Alberto del Rio Espinola, PhD
Director, Translational Sciences
Victoria DeVault, PhD
Senior Scientist
Aaron Deykin, MD
CMO, Head of R&D, Upstream Bio, Board Director
Emily Doll, BS
Associate Director, Accounting Operations
Kaya Epstein, BS
Associate Scientist II
Jaii Fredregill, BA
Executive Assistant
Dalia Gaddis, PhD
Principal Scientist
Irena Gettinger, BS
Development Scientist I
Carl Gordon, PhD, CFA
Managing Partner & Head of Global Private Equity, OrbiMed, Director
Maggie Gose, BA
Principal Development Associate Scientist
Gidi Gross, PhD
Professor & PI, MIGAL and Scientific Co-Founder
Tim Guo, PhD
Senior Scientist
Kevin Hawkins, BA
Development Scientist II
Hatem Heikal, MBA
VP, Finance
Maegan Hoover, MS
Scientist I
Scott Hussell, BA
Senior Scientist, Analytical Development
Adan Jaramillo, BA
Senior Director, Quality
Amy Jennings, PhD
Principal, RegPath Consulting
Hunter Kellogg, MS
Associate Scientist II
Priya Saikumar Lakshmi, PhD
Scientist II
Ashley Landuyt, PhD
Scientist II
Jennifer Mellen, BS
Principal Associate Scientist
Christopher L. Moore, PhD
Director, Discovery
Mirna Mujacic, PhD
VP, Process and Analytical Development
Conor O’Brien, Ph.D.
Senior Engineer
Brian Oliver, PhD
Principal Development Scientist
Chandra Patel, PhD
Co-founder and VP, Research and Development Operations
Stanford Peng, MD, PhD
President, R&D, Alpine Immune Sciences
Alexa Perdikis, BS
Associate Director, Talent Acquisition & Employee Experience
Jonathan Pritz, PhD
Analyst, RA Capital, Board Observer
Margaret Readio, BS
Director, Head of Technical Development Operations
Nicole Reid, BS
Associate Scientist II, Discovery
Marko Repic, PhD
Director, Pharmacology/Toxicology
David Rawlings, MD
Director, Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Scientific Co-founder and Senior Scientific Advisor
Pramod Rompikuntal, PhD
Principal Scientist
Martina Sassone-Corsi, MS
Senior Scientist
Andy Scharenberg, MD
Scientific Co-founder, SAB Chair, CEO, Umoja Biopharma
Poonam Sharma, PhD
Senior Engineer
Nandita Shangari, PhD
Managing Director RA Capital, Board Director
Chuck Silberstein, MD, MBA
Chief Financial Officer
Michal Silverberg, MBA, MS
Managing Director, Novartis Venture Fund, Board Director
Nishat Shaikh, JD
VP, Intellectual Property & Contracts
Andrew Stuart, BS
Principal Development Associate Scientist
Andy Tran
Biotech Investor, Matrix Capital Management, Board Director
David Tucker, PhD
Principal Scientist
Gene Uenishi, PhD
Associate Director, Discovery
Shivali Verma, BA
Associate Scientist II
Andy Walker, PhD
Co-founder, President, and COO
Hadas Weinstein-Marom, PhD
Senior Scientist & Lecturer, MIGAL, Scientific Co-Founder
John Wesner, MS
Director, Process Development
Tom Wickham, PhD
Chief Scientific Officer
Jennifer Yam, MS
Principal Associate Scientist
Rachel Yost, BS
Associate Director, MSAT
Payam Zarin, PhD
Principal Scientist